 Stephanie Dillon
Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 25 | 2022 | 2470 | 3.470 |
Why?
| | Intestinal Mucosa | 12 | 2021 | 528 | 3.120 |
Why?
| | Gastrointestinal Microbiome | 12 | 2022 | 502 | 3.060 |
Why?
| | HIV-1 | 18 | 2022 | 768 | 2.560 |
Why?
| | Dysbiosis | 9 | 2022 | 146 | 2.510 |
Why?
| | CD4-Positive T-Lymphocytes | 14 | 2022 | 965 | 2.100 |
Why?
| | Dendritic Cells | 16 | 2020 | 436 | 1.950 |
Why?
| | Immunity, Mucosal | 5 | 2017 | 84 | 1.620 |
Why?
| | Colon | 7 | 2022 | 233 | 1.460 |
Why?
| | Gastrointestinal Tract | 5 | 2022 | 169 | 1.410 |
Why?
| | Microbiota | 5 | 2023 | 648 | 1.270 |
Why?
| | Lymphocyte Activation | 8 | 2017 | 1042 | 1.230 |
Why?
| | Bacterial Translocation | 4 | 2019 | 36 | 1.190 |
Why?
| | Interferon-gamma | 10 | 2019 | 724 | 0.950 |
Why?
| | Th1 Cells | 3 | 2019 | 123 | 0.780 |
Why?
| | Butyrates | 2 | 2021 | 53 | 0.730 |
Why?
| | Immunity, Innate | 4 | 2021 | 723 | 0.670 |
Why?
| | Th17 Cells | 1 | 2019 | 59 | 0.660 |
Why?
| | Escherichia coli | 5 | 2014 | 720 | 0.650 |
Why?
| | Salmonella typhimurium | 3 | 2021 | 160 | 0.620 |
Why?
| | Interferon Type I | 1 | 2018 | 128 | 0.580 |
Why?
| | Granzymes | 3 | 2022 | 40 | 0.550 |
Why?
| | Immunologic Factors | 1 | 2018 | 221 | 0.540 |
Why?
| | Killer Cells, Natural | 2 | 2019 | 383 | 0.510 |
Why?
| | Mucous Membrane | 2 | 2015 | 108 | 0.500 |
Why?
| | Escherichia coli Infections | 2 | 2013 | 100 | 0.500 |
Why?
| | Bacteria | 2 | 2022 | 728 | 0.490 |
Why?
| | Lymphocytes | 3 | 2021 | 335 | 0.470 |
Why?
| | Interleukin-23 | 2 | 2013 | 15 | 0.470 |
Why?
| | T-Lymphocytes | 5 | 2021 | 1748 | 0.470 |
Why?
| | Lymphocyte Subsets | 1 | 2014 | 79 | 0.450 |
Why?
| | CD8-Positive T-Lymphocytes | 4 | 2015 | 691 | 0.440 |
Why?
| | Immunity | 1 | 2014 | 121 | 0.430 |
Why?
| | Inflammation | 5 | 2021 | 2485 | 0.430 |
Why?
| | Flow Cytometry | 9 | 2017 | 1084 | 0.430 |
Why?
| | Endotoxemia | 1 | 2014 | 82 | 0.430 |
Why?
| | Immune Tolerance | 3 | 2014 | 329 | 0.400 |
Why?
| | Toll-Like Receptor 8 | 1 | 2010 | 5 | 0.360 |
Why?
| | Middle Aged | 19 | 2021 | 26873 | 0.350 |
Why?
| | Humans | 42 | 2023 | 115222 | 0.350 |
Why?
| | Toll-Like Receptor 7 | 1 | 2010 | 35 | 0.350 |
Why?
| | Aging | 1 | 2020 | 1624 | 0.350 |
Why?
| | Adult | 21 | 2020 | 30711 | 0.350 |
Why?
| | Viremia | 1 | 2010 | 122 | 0.340 |
Why?
| | Caspase 3 | 1 | 2010 | 237 | 0.340 |
Why?
| | Young Adult | 11 | 2020 | 10520 | 0.340 |
Why?
| | Myeloid Cells | 1 | 2010 | 127 | 0.330 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 213 | 0.330 |
Why?
| | Membrane Glycoproteins | 3 | 2015 | 429 | 0.320 |
Why?
| | Viral Load | 5 | 2015 | 405 | 0.320 |
Why?
| | Ruminococcus | 2 | 2021 | 9 | 0.320 |
Why?
| | Interleukin-17 | 3 | 2023 | 104 | 0.310 |
Why?
| | Toll-Like Receptor 2 | 2 | 2006 | 109 | 0.310 |
Why?
| | Lymphoid Tissue | 1 | 2008 | 62 | 0.300 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2006 | 164 | 0.280 |
Why?
| | Oncogene Proteins, Viral | 1 | 2007 | 20 | 0.280 |
Why?
| | Human papillomavirus 16 | 1 | 2007 | 25 | 0.280 |
Why?
| | Interferon-alpha | 2 | 2020 | 186 | 0.280 |
Why?
| | Cross-Sectional Studies | 4 | 2018 | 4419 | 0.280 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2007 | 39 | 0.280 |
Why?
| | Papillomavirus Infections | 2 | 2007 | 258 | 0.270 |
Why?
| | Zymosan | 1 | 2006 | 63 | 0.270 |
Why?
| | Th2 Cells | 2 | 2004 | 155 | 0.270 |
Why?
| | Antiviral Agents | 3 | 2020 | 647 | 0.260 |
Why?
| | Antigen-Presenting Cells | 1 | 2006 | 153 | 0.260 |
Why?
| | Virus Replication | 3 | 2015 | 393 | 0.260 |
Why?
| | Immunoglobulin A | 2 | 2022 | 171 | 0.250 |
Why?
| | Apoptosis | 2 | 2014 | 2368 | 0.250 |
Why?
| | Interleukin-10 | 6 | 2013 | 297 | 0.250 |
Why?
| | Cells, Cultured | 7 | 2021 | 3897 | 0.240 |
Why?
| | Receptors, Cell Surface | 2 | 2021 | 356 | 0.240 |
Why?
| | Leukocytes, Mononuclear | 4 | 2018 | 496 | 0.230 |
Why?
| | Biopsy | 3 | 2018 | 1050 | 0.230 |
Why?
| | Receptors, IgG | 2 | 2014 | 67 | 0.220 |
Why?
| | Male | 20 | 2020 | 55814 | 0.220 |
Why?
| | Enterobacteriaceae | 2 | 2017 | 32 | 0.220 |
Why?
| | Antigens, CD1 | 2 | 2015 | 57 | 0.210 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2004 | 278 | 0.210 |
Why?
| | Aged | 9 | 2021 | 19136 | 0.210 |
Why?
| | Female | 19 | 2020 | 59720 | 0.210 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 17 | 0.210 |
Why?
| | Phenotype | 4 | 2019 | 2814 | 0.210 |
Why?
| | MAP Kinase Signaling System | 1 | 2004 | 276 | 0.200 |
Why?
| | Nerve Tissue Proteins | 1 | 2006 | 531 | 0.200 |
Why?
| | Arthritis, Experimental | 1 | 2023 | 132 | 0.200 |
Why?
| | Interleukin-2 | 2 | 2022 | 415 | 0.200 |
Why?
| | Acinetobacter | 1 | 2021 | 13 | 0.190 |
Why?
| | Antigens, CD | 3 | 2015 | 441 | 0.190 |
Why?
| | Glycoproteins | 2 | 2015 | 305 | 0.190 |
Why?
| | Interleukin-15 | 1 | 2021 | 75 | 0.190 |
Why?
| | Aged, 80 and over | 3 | 2021 | 6358 | 0.180 |
Why?
| | DNA-Binding Proteins | 2 | 2007 | 1318 | 0.180 |
Why?
| | Interferon-beta | 1 | 2020 | 79 | 0.180 |
Why?
| | Interleukin-12 | 5 | 2012 | 110 | 0.170 |
Why?
| | Bacteria, Anaerobic | 1 | 2020 | 20 | 0.170 |
Why?
| | Membrane Proteins | 1 | 2006 | 1019 | 0.170 |
Why?
| | Monocytes | 2 | 2013 | 503 | 0.170 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2021 | 198 | 0.170 |
Why?
| | Adaptive Immunity | 1 | 2021 | 156 | 0.170 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2019 | 68 | 0.160 |
Why?
| | Gram-Positive Bacteria | 1 | 2019 | 45 | 0.160 |
Why?
| | Gram-Negative Bacteria | 1 | 2019 | 66 | 0.160 |
Why?
| | CD4 Lymphocyte Count | 3 | 2014 | 257 | 0.160 |
Why?
| | Diet, High-Fat | 1 | 2019 | 225 | 0.150 |
Why?
| | Feces | 2 | 2019 | 373 | 0.150 |
Why?
| | Gene Expression Profiling | 3 | 2020 | 1524 | 0.150 |
Why?
| | Antigen Presentation | 1 | 1998 | 189 | 0.140 |
Why?
| | Immunoglobulins | 2 | 2015 | 143 | 0.140 |
Why?
| | Case-Control Studies | 4 | 2020 | 3023 | 0.140 |
Why?
| | Body Composition | 1 | 2021 | 586 | 0.140 |
Why?
| | Interleukins | 1 | 2019 | 236 | 0.140 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2021 | 192 | 0.140 |
Why?
| | CD40 Antigens | 2 | 2015 | 82 | 0.140 |
Why?
| | GPI-Linked Proteins | 2 | 2014 | 56 | 0.140 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 80 | 0.140 |
Why?
| | Cell Proliferation | 5 | 2021 | 2192 | 0.130 |
Why?
| | Age Factors | 3 | 2019 | 2900 | 0.130 |
Why?
| | DNA, Bacterial | 1 | 2017 | 311 | 0.130 |
Why?
| | Tuberculosis | 1 | 1998 | 241 | 0.130 |
Why?
| | Cluster Analysis | 1 | 2017 | 458 | 0.130 |
Why?
| | Arthritis, Rheumatoid | 1 | 2023 | 1002 | 0.130 |
Why?
| | Prevotella | 1 | 2015 | 12 | 0.130 |
Why?
| | Immunophenotyping | 2 | 2014 | 276 | 0.120 |
Why?
| | Colitis | 1 | 2017 | 226 | 0.120 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2017 | 487 | 0.120 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 2 | 2006 | 146 | 0.120 |
Why?
| | Receptors, Peptide | 1 | 2014 | 20 | 0.120 |
Why?
| | CD56 Antigen | 1 | 2014 | 34 | 0.120 |
Why?
| | Toll-Like Receptor 3 | 1 | 2014 | 26 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 728 | 0.110 |
Why?
| | Intestines | 1 | 2017 | 322 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 2 | 2014 | 383 | 0.110 |
Why?
| | Spleen | 2 | 2006 | 486 | 0.110 |
Why?
| | Cell Lineage | 1 | 2015 | 310 | 0.110 |
Why?
| | Phylogeny | 1 | 2017 | 796 | 0.110 |
Why?
| | Homeostasis | 1 | 2017 | 578 | 0.110 |
Why?
| | Cell Separation | 2 | 2014 | 291 | 0.110 |
Why?
| | Pilot Projects | 1 | 2017 | 1377 | 0.110 |
Why?
| | Lipoproteins | 2 | 2004 | 160 | 0.110 |
Why?
| | Bacteroides fragilis | 1 | 2012 | 11 | 0.100 |
Why?
| | Fetal Tissue Transplantation | 2 | 2003 | 35 | 0.100 |
Why?
| | Cytokines | 3 | 2010 | 1843 | 0.100 |
Why?
| | Enterococcus | 1 | 2012 | 18 | 0.100 |
Why?
| | Lymphocyte Depletion | 1 | 2012 | 116 | 0.100 |
Why?
| | Lipopolysaccharides | 2 | 2006 | 818 | 0.100 |
Why?
| | Diet | 2 | 2019 | 1075 | 0.090 |
Why?
| | Mice, Inbred C57BL | 4 | 2006 | 4718 | 0.090 |
Why?
| | Genes, bcl-2 | 1 | 2010 | 20 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2006 | 2586 | 0.090 |
Why?
| | Signal Transduction | 4 | 2021 | 4527 | 0.090 |
Why?
| | Biodiversity | 1 | 2014 | 358 | 0.090 |
Why?
| | Mice, Transgenic | 2 | 2006 | 1956 | 0.090 |
Why?
| | Mice | 7 | 2023 | 14934 | 0.090 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 43 | 0.080 |
Why?
| | Chemotaxis | 1 | 2009 | 130 | 0.080 |
Why?
| | Parkinson Disease | 2 | 2003 | 323 | 0.080 |
Why?
| | Toll-Like Receptor 4 | 2 | 2013 | 286 | 0.070 |
Why?
| | Interleukin-1beta | 2 | 2019 | 370 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 515 | 0.070 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2007 | 170 | 0.070 |
Why?
| | Animals | 8 | 2023 | 31884 | 0.070 |
Why?
| | Hepatitis C, Chronic | 1 | 2009 | 152 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 172 | 0.070 |
Why?
| | Capsid Proteins | 1 | 2007 | 69 | 0.070 |
Why?
| | Adolescent | 2 | 2019 | 17889 | 0.070 |
Why?
| | Body Mass Index | 1 | 2014 | 1968 | 0.070 |
Why?
| | Lectins, C-Type | 1 | 2006 | 61 | 0.070 |
Why?
| | HIV | 1 | 2007 | 208 | 0.070 |
Why?
| | Ligands | 2 | 2007 | 565 | 0.070 |
Why?
| | Yeasts | 1 | 2006 | 49 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2330 | 0.070 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2006 | 50 | 0.060 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2007 | 174 | 0.060 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2012 | 1138 | 0.060 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 157 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 1 | 2006 | 396 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 15 | 0.060 |
Why?
| | Neurons | 2 | 2003 | 1285 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2120 | 0.060 |
Why?
| | Enzyme Induction | 1 | 2004 | 84 | 0.060 |
Why?
| | Vaccines, DNA | 1 | 2004 | 30 | 0.060 |
Why?
| | CD11c Antigen | 1 | 2004 | 38 | 0.060 |
Why?
| | CD11b Antigen | 1 | 2004 | 58 | 0.060 |
Why?
| | Antigens, Differentiation | 1 | 2004 | 79 | 0.060 |
Why?
| | Dipeptides | 1 | 2004 | 48 | 0.060 |
Why?
| | Ovalbumin | 1 | 2004 | 162 | 0.060 |
Why?
| | Dopamine | 2 | 2003 | 236 | 0.060 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2004 | 90 | 0.060 |
Why?
| | Papillomaviridae | 1 | 2004 | 100 | 0.060 |
Why?
| | Antibodies, Viral | 1 | 2007 | 522 | 0.060 |
Why?
| | Transforming Growth Factor beta | 1 | 2006 | 448 | 0.050 |
Why?
| | Anti-Allergic Agents | 1 | 2003 | 41 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 164 | 0.050 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 166 | 0.050 |
Why?
| | Protein Subunits | 1 | 2004 | 201 | 0.050 |
Why?
| | Viral Vaccines | 1 | 2004 | 89 | 0.050 |
Why?
| | Cell Differentiation | 1 | 2010 | 1700 | 0.050 |
Why?
| | Receptors, Immunologic | 1 | 2004 | 201 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2007 | 775 | 0.050 |
Why?
| | Tryptophan | 1 | 2023 | 135 | 0.050 |
Why?
| | Time Factors | 2 | 2006 | 6157 | 0.050 |
Why?
| | Interleukin-6 | 1 | 2006 | 676 | 0.050 |
Why?
| | Immunoglobulin E | 1 | 2003 | 323 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 112 | 0.050 |
Why?
| | Propionates | 1 | 2021 | 34 | 0.050 |
Why?
| | Eosinophilia | 1 | 2003 | 186 | 0.050 |
Why?
| | Collagen | 1 | 2023 | 416 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2004 | 371 | 0.050 |
Why?
| | Control Groups | 1 | 2001 | 10 | 0.050 |
Why?
| | Brain Tissue Transplantation | 1 | 2001 | 19 | 0.050 |
Why?
| | Papillomavirus Vaccines | 1 | 2004 | 222 | 0.050 |
Why?
| | Mesencephalon | 1 | 2001 | 57 | 0.050 |
Why?
| | Acetates | 1 | 2021 | 95 | 0.050 |
Why?
| | Acetylation | 1 | 2021 | 211 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1155 | 0.040 |
Why?
| | Interleukin-12 Subunit p35 | 1 | 2019 | 3 | 0.040 |
Why?
| | Phosphorylation | 1 | 2004 | 1574 | 0.040 |
Why?
| | Immunologic Memory | 2 | 2014 | 313 | 0.040 |
Why?
| | Macrophages | 1 | 2006 | 1267 | 0.040 |
Why?
| | Tight Junctions | 1 | 2019 | 68 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1638 | 0.040 |
Why?
| | Tuberculin | 1 | 1998 | 6 | 0.040 |
Why?
| | Fatty Acids, Volatile | 1 | 2019 | 47 | 0.040 |
Why?
| | Freund's Adjuvant | 1 | 1998 | 17 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2019 | 219 | 0.040 |
Why?
| | HIV Seropositivity | 1 | 2019 | 110 | 0.040 |
Why?
| | Metagenome | 1 | 2019 | 122 | 0.040 |
Why?
| | Up-Regulation | 2 | 2014 | 812 | 0.040 |
Why?
| | Metagenomics | 1 | 2019 | 131 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2109 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2021 | 629 | 0.040 |
Why?
| | Disease Progression | 2 | 2019 | 2390 | 0.030 |
Why?
| | Histones | 1 | 2021 | 535 | 0.030 |
Why?
| | Epitopes | 1 | 1998 | 436 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 558 | 0.030 |
Why?
| | Virion | 1 | 2015 | 73 | 0.030 |
Why?
| | Computational Biology | 1 | 2019 | 532 | 0.030 |
Why?
| | Biomarkers | 2 | 2019 | 3422 | 0.030 |
Why?
| | Antigens, CD19 | 1 | 2014 | 97 | 0.030 |
Why?
| | Caspase 1 | 1 | 2014 | 140 | 0.030 |
Why?
| | Chronic Disease | 2 | 2009 | 1594 | 0.030 |
Why?
| | Tomography, Emission-Computed | 2 | 2003 | 58 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1036 | 0.020 |
Why?
| | Blood | 1 | 2012 | 97 | 0.020 |
Why?
| | Liver | 1 | 2019 | 1688 | 0.020 |
Why?
| | Transcriptome | 1 | 2017 | 725 | 0.020 |
Why?
| | Cell Survival | 1 | 2014 | 1022 | 0.020 |
Why?
| | Chloroquine | 1 | 2009 | 52 | 0.020 |
Why?
| | Reference Standards | 1 | 2009 | 160 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 1731 | 0.020 |
Why?
| | Double-Blind Method | 2 | 2003 | 1665 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 32 | 0.020 |
Why?
| | Gene Products, gag | 1 | 2007 | 36 | 0.020 |
Why?
| | Anti-Infective Agents | 1 | 2009 | 225 | 0.020 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 139 | 0.020 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2007 | 193 | 0.020 |
Why?
| | Lymph Nodes | 1 | 2007 | 422 | 0.020 |
Why?
| | beta-Galactosidase | 1 | 2004 | 62 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1781 | 0.010 |
Why?
| | Schistosoma mansoni | 1 | 2003 | 33 | 0.010 |
Why?
| | Putamen | 1 | 2003 | 14 | 0.010 |
Why?
| | Antiparkinson Agents | 1 | 2003 | 26 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2004 | 257 | 0.010 |
Why?
| | Antigens, Viral | 1 | 2004 | 176 | 0.010 |
Why?
| | Craniotomy | 1 | 2003 | 67 | 0.010 |
Why?
| | Models, Animal | 1 | 2004 | 349 | 0.010 |
Why?
| | Treatment Failure | 1 | 2003 | 332 | 0.010 |
Why?
| | Viral Proteins | 1 | 2004 | 281 | 0.010 |
Why?
| | Dihydroxyphenylalanine | 1 | 2001 | 7 | 0.010 |
Why?
| | Fluorine Radioisotopes | 1 | 2001 | 10 | 0.010 |
Why?
| | Culture Techniques | 1 | 2001 | 80 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2003 | 1130 | 0.010 |
Why?
| | Allergens | 1 | 2003 | 417 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2003 | 913 | 0.010 |
Why?
| | Cell Line | 1 | 2004 | 2645 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2004 | 2806 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2009 | 9151 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2001 | 2552 | 0.010 |
Why?
| | Brain | 1 | 2001 | 2378 | 0.010 |
Why?
|
|
Dillon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|